Advances delivered what may feel like medical miracles, including the first bladder transplant, a lifesaving personalized ...

Apple, Michigan taxpayers, and one of Detroit’s wealthiest families spent roughly $30 million training hundreds of people to ...

UBC Okanagan researchers have uncovered how plants create mitraphylline, a rare natural compound linked to anti-cancer ...

OTR Therapeutics may still be keeping its own pipeline under wraps, but Zealand Pharma has seen enough promise in the Chinese biotech’s platform to agree to up to $30 million in upfront payments.

An unusual tussle over the availability of funds for Apple Tree’s startups led the firm to seek protection from creditors while it restructures. ATP’s filing was made under Chapter 11 of the U.S.

Yes, we are in M&A conversations, and yes, if we find a win win situation where consolidation can lead to a stronger entity, we will go ahead with this, Unacademy co-founder Gaurav Munjal said in a ...

Unacademy, once one of India’s best-known edtech startups, may now be worth less than $500 million, 85% less than its pandemic-era peak valuation, as the company undergoes a steep reset and explores ...

A Chinese biotech helmed by an AstraZeneca veteran has secured $108 million in series B funds, which the company will use to advance its lead KRAS inhibitor into phase 3 studies. D3 Bio saw previous ...

Ancient events in plant evolution have left behind large, duplicated regions in their genomes. Salk Institute scientists found that deleting these large blocks of DNA can still lead to normal plants.

The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists. Obviously, the broken promise is a ...